
MetLife Inc
NYSE:MET

Intrinsic Value
The intrinsic value of one
MET
stock under the Base Case scenario is
149.01
USD.
Compared to the current market price of 72.55 USD,
MetLife Inc
is
Undervalued by 51%.
The Intrinsic Value is calculated as the average of DCF and Relative values:

Valuation History
MetLife Inc
Fundamental Analysis

MetLife’s balance sheet could face significant pressure if interest rates move unpredictably and create mismatches between its long-duration liabilities and investment portfolio, exposing the company to capital volatility and higher compliance costs to maintain strict solvency ratios.
MetLife’s global footprint and diversified product lineup—spanning life insurance, retirement solutions, and employee benefits—position it well to capture growth opportunities across various economic cycles and shield it from localized downturns.

Balance Sheet Decomposition
MetLife Inc
Cash & Short-Term Investments | 20.1B |
Deferred Policy Acquisition Cost | 19.6B |
Long-Term Investments | 428.4B |
Other Assets | 209.4B |
Wall St
Price Targets
MET Price Targets Summary
MetLife Inc
According to Wall Street analysts, the average 1-year price target for
MET
is 100.39 USD
with a low forecast of 87.87 USD and a high forecast of 115.5 USD.
Dividends
Current shareholder yield for MET is
.
Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?
The intrinsic value of one
MET
stock under the Base Case scenario is
149.01
USD.
Compared to the current market price of 72.55 USD,
MetLife Inc
is
Undervalued by 51%.